Arcturus Therapeutics Holdings Inc.

NasdaqGM:ARCT Stock Report

Mkt Cap: US$527.9m

Arcturus Therapeutics Holdings Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Joe Payne (50 yo)

9.83yrs

Tenure

US$960,000

Compensation

Mr. Joseph E. Payne, also known as Joe, M.Sc., has been Independent Non-Executive Director of Vallon Pharmaceuticals, Inc. since June 22, 2018. Mr. Payne has been Director of Arcturus since November 2017....


CEO Compensation Analysis

How has Joe Payne's remuneration changed compared to Arcturus Therapeutics Holdings's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$147m

Jun 30 2022n/an/a

-US$165m

Mar 31 2022n/an/a

-US$198m

Dec 31 2021US$960kUS$600k

-US$204m

Sep 30 2021n/an/a

-US$196m

Jun 30 2021n/an/a

-US$163m

Mar 31 2021n/an/a

-US$119m

Dec 31 2020US$13mUS$500k

-US$72m

Sep 30 2020n/an/a

-US$52m

Jun 30 2020n/an/a

-US$38m

Mar 31 2020n/an/a

-US$29m

Dec 31 2019US$1mUS$450k

-US$26m

Sep 30 2019n/an/a

-US$16m

Jun 30 2019n/an/a

-US$13m

Mar 31 2019n/an/a

-US$22m

Dec 31 2018US$3mUS$425k

-US$22m

Sep 30 2018n/an/a

-US$26m

Jun 30 2018n/an/a

-US$25m

Mar 31 2018n/an/a

-US$16m

Dec 31 2017US$449kUS$384k

-US$11m

Compensation vs Market: Joe's total compensation ($USD960.00K) is below average for companies of similar size in the US market ($USD2.52M).

Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Joseph Payne
Founder9.83yrsUS$960.00k5.57%
$ 29.4m
Padmanabh Chivukula
Founder10yrsUS$750.00k2.24%
$ 11.8m
Andrew Sassine
CFO & Director4.42yrsUS$750.00k1.01%
$ 5.4m
Lance Kurata
Chief Legal Officer2.42yrsUS$560.00kno data
Steven Hughes
Strategic Clinical Advisor & Member of Scientific Advisory Board3yrsUS$644.00kno data
Keith Kummerfeld
VP of Finance & Corporate Controller4.33yrsno datano data
Dushyant Varshney
Executive VP & Chief Technology Officerno datano datano data
Deepankar Roy
Senior Director of Investor Relationsno datano datano data
Kyle Gutstadt
Senior Analyst of Investor & Public Relationsno datano datano data
Kevin Skol
Chief Business Officer4.33yrsno datano data
Kelly Lindert
Chief Development Officer1yrno datano data

4.3yrs

Average Tenure

52yo

Average Age

Experienced Management: ARCT's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Joseph Payne
Founder9.83yrsUS$960.00k5.57%
$ 29.4m
Andrew Sassine
CFO & Director3.33yrsUS$750.00k1.01%
$ 5.4m
Steven Hughes
Strategic Clinical Advisor & Member of Scientific Advisory Board0.83yrUS$644.00kno data
Peter Farrell
Independent Chairman of the Board4.67yrsUS$389.78k0.36%
$ 1.9m
Edward Holmes
Independent Director3.33yrsUS$377.28kno data
James Barlow
Independent Director4.67yrsUS$387.28k0.038%
$ 198.8k
Magda Marquet
Independent Director4.67yrsUS$377.28k0.086%
$ 451.7k
Frederick Hayden
Member of the Vaccine Platform Scientific Advisory Board2.5yrsno datano data
Michael Hodges
Member of Scientific Advisory Board8.08yrsno datano data
Drew Weissman
Member of Scientific Advisory Board7.17yrsno datano data
Jeffrey Colyer
Member of the Vaccine Platform Scientific Advisory Board2.5yrsno datano data
Eng Ooi
Member of the Vaccine Platform Scientific Advisory Board2.5yrsno datano data

4.0yrs

Average Tenure

63yo

Average Age

Experienced Board: ARCT's board of directors are considered experienced (4 years average tenure).